Please select the option that best describes you:
Topics:
Cardiology • Interventional Cardiology
Following completion of antiplatelet monotherapy (i.e., Plavix) plus oral anticoagulation in patients with AFib post-PCI, would you favor continuing antiplatelet therapy + OAC, switching from Plavix to aspirin and continuing OAC, or stopping antiplatelet therapy and continuing OAC?
Answer from: at Community Practice
To avoid confusion with different styles within our system, we have adopted a standard practice in our lab to use triple therapy for 1 week. Then after 1 week, we drop ASA. We tend to prefer ASA, clopidogrel + OAC. But if they could not take clopidogrel (for any reason) then we still use the same pr...
Answer from: at Community Practice
The current ACC guidelines recommend stopping anti-platelet agent after one year and continuing DOACs.
Comments
at Kaiser Permanente Panorama City Medical Center
After 1 year, I prefer to continue OAC and Plavix.
After 1 year, I prefer to continue OAC and Plavix.
It raised interesting questions. How long to use ...